Skip to main content
Shaping Europe’s digital future logo

Special Group - Signatories of the Declaration: ‘Towards access to at least 1 million sequenced genomes in the European Union by 2022’ (1+MG Group)

The 1+MG Group was created by the European Commission to support the coordination and cooperation regarding the implementation of Member States’ 2018 Declaration ‘Towards access to at least 1 million sequenced genomes in the European Union by 2022’.

© hh5800 - iStock Getty Images Plus

The Group’s mandate is to:  

  1. ensure good coordination and cooperation between the Commission and Member States on the implementation of the 1+MG Declaration;
  2. build consensus and commitment among the signatory countries as regards the formulation and implementation of strategic choices/orientations related to the priorities and actions outlined in the 1+MG Declaration;
  3. endorse/give feedback on the outcomes and outputs of the work in the operational/expert layer (1+MG working groups);
  4. formulate strategic steer to the operational/expert layer working on the detailed aspects of the implementation of the 1+MG Declaration;
  5. occasionally, advise the Commission on policies, legislative proposals and other instruments or regulatory frameworks related to genomic data.

The European Commission co-chairs the meetings of the 1+MG Group together with a representative of the signatory countries elected in the first meeting. DG CNECT provides the secretariat of the Group.

The group meets up to four times per year. 

The European Commission is making available meeting agendas and minutes.

Members

Signatory countries of the 1+MG Declaration were invited to nominate up to 2 members per country from among national authorities or other public entities responsible for health policy and research. EU and EEA countries that have not signed the Declaration may nominate observers to the Group. 

Meetings

1st meeting of the Group, 18 March 2021

2nd meeting of the Group, 1 July 2021

 

Related Content

Big Picture

European '1+ Million Genomes' Initiative

The 1+ Million Genomes initiative has the potential to improve disease prevention, allow for more personalised treatments and provide new impactful research.